Amgen Inc. plans to finance its acquisition of Horizon Therapeutics in the corporate bond market, underscoring how the Federal Reserve’s inflation fight isn’t drying up mega deals on Wall Street.
More Stories
The surprising math of immigration, Social Security and Medicare
Immigration will have an effect on your retirement — but it’s probably not what you think.
New York’s pot business on track to join $1 billion legal state sales club
New York State may approach $1 billion in legal pot sales this year as its legal cannabis business gains traction...
Nike’s stock has been dogged by these issues. Can a new CEO change the game?
New Nike CEO Elliot Hill is inheriting “a turnaround that has yet to show momentum,” according to Stifel analyst Jim...
Electric vehicles are suddenly the best deal in the used-car market
The average monthly payment on used electric vehicles, which are now cheaper than hybrids and gas-engine cars, are approaching affordable...
IBD and MarketWatch’s fifth annual survey of the most trusted financial companies
Consumers have cast their votes for the financial services companies they trust the most
Stocks at risk of a bubble after Fed’s jumbo rate cut, BofA strategist says
One Bank of America strategist thinks the Federal Reserve’s decision to cut interest-rates by 50 basis points this week will...